Technescan Pyp (Technetium Tc 99m Pyrophosphate) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Technescan Pyp. Always confirm against the full prescribing information.
42 interactions
Calcium
Calcium can cause a decrease in the absorption of Pyrophosphoric acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Calcium acetate
Calcium acetate can cause a decrease in the absorption of Pyrophosphoric acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Calcium carbonate
Calcium carbonate can cause a decrease in the absorption of Pyrophosphoric acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Calcium chloride
Calcium chloride can cause a decrease in the absorption of Pyrophosphoric acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Calcium citrate
Calcium citrate can cause a decrease in the absorption of Pyrophosphoric acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Calcium glucoheptonate
Calcium glucoheptonate can cause a decrease in the absorption of Pyrophosphoric acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Calcium gluconate
Calcium gluconate can cause a decrease in the absorption of Pyrophosphoric acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Calcium lactate
Calcium lactate can cause a decrease in the absorption of Pyrophosphoric acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Calcium Phosphate
Calcium Phosphate can cause a decrease in the absorption of Pyrophosphoric acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Calcium polycarbophil
Calcium polycarbophil can cause a decrease in the absorption of Pyrophosphoric acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Sucralfate
Sucralfate can cause a decrease in the absorption of Pyrophosphoric acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Aluminum hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Pyrophosphoric acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Technescan Pyp (Technetium Tc 99m Pyrophosphate) has 42 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Technescan Pyp (Technetium Tc 99m Pyrophosphate) has 0 major, 11 moderate, and 31 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Technescan Pyp. Always confirm against the full prescribing information.